LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Articles
United Neuroscience Ltd.
Headquarters:
Dublin, Ireland
Website:
N/A
Year Founded:
2014
Status:
Merged
BioCentury
|
Nov 7, 2020
Emerging Company Profile
Vaxxinity: supplanting mAbs with vaccines for chronic disease
Emerging Company Profile: after its COVID-19 vaccine, Vaxxinity plans to take on mAbs for chronic diseases with vaccines against the same targets
Read More
BioCentury
|
Jan 18, 2019
Clinical News
United Neuroscience's vaccine leads to 96% response rate in Chinese Phase IIa for Alzheimer's
Read More
BioCentury
|
Dec 22, 2018
Company News
Management tracks: United Neuroscience, Zymergen
Read More
BioCentury
|
May 4, 2018
Emerging Company Profile
Needling out Alzheimer’s
How AD vaccine UB-311 could be safer than other anti-beta amyloid therapies
Read More
BioCentury
|
Apr 13, 2018
Company News
UT Southwestern to evaluate United Neuroscience's Endobody vaccine candidates
Read More
BioCentury
|
Mar 30, 2018
Company News
United Neuroscience, CNRS to target alpha synuclein to treat PD
Read More
BioCentury
|
Jun 2, 2017
Clinical News
United Neuroscience reports Phase I data for AD vaccine UB-311
Read More
Items per page:
10
1 - 7 of 7